Skip to main content
Erschienen in: Inflammation 1/2018

14.09.2017 | ORIGINAL ARTICLE

Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role

verfasst von: Kohki Okada, Hiroshi Itoh, Yasuhiko Kamikubo, Souichi Adachi, Masaki Ikemoto

Erschienen in: Inflammation | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The innate properties of S100A8 as a regulator in acute inflammation have not yet been elucidated in detail. Our aims are to newly establish S100A8 transgenic rats (Tg-S100A8) and to elucidate the immunological functions of S100A8. Following the treatment with 5% dextran sulfate sodium for 1 week, the body weight in Tg-S100A8 weakly decreased after the start; however, that in Japanese Wistar rats (WT) significantly decreased in the end. The serum level of CRP in Tg-S100A8 was significantly lower than that in WT, although the concentration of CRP apparently increased in both Tg-S100A8 and WT. The dynamic mobility of S100A8 and S100A9 in macrophages was microscopically observed using fluorescent immunological staining, in which the S100A9 was dominantly expressed in many macrophages in the rectal tissue of WT. As determined by PCR and real-time PCR, the levels of S100A8 messenger RNA (mRNA) in several organ tissues of the Tg-S100A8, such as heart and small intestine, were apparently higher than those of WT, respectively. The expression of IL-6 and TNF-α mRNAs was negatively regulated in main organ tissues of the large colon of Tg-S100A8 followed by down-regulation of IL-6 protein. An important result was that the expression of S100A8 mRNA was strongly induced in many macrophages of Tg-S100A8, whereas that of some inflammatory cytokine mRNAs described above were significantly reduced. Tg-S100A8 has potential as a useful experimental model rat not only for investigating the innate properties of S100A8 as a regulator, but also for clarifying its functional role in immune cells from a myeloid origin, particularly macrophages.
Literatur
1.
Zurück zum Zitat Odink, K., N. Gerletti, J. Bruggen, R.G. Clerc, L. Tarcsay, G. Zwadlo, G. Gerhards, R. Schlegel, and C. Sorg. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.CrossRefPubMed Odink, K., N. Gerletti, J. Bruggen, R.G. Clerc, L. Tarcsay, G. Zwadlo, G. Gerhards, R. Schlegel, and C. Sorg. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82.CrossRefPubMed
2.
Zurück zum Zitat Nacken, W., J. Roth, C. Sorg, and C. Kerkhoff. 2003. S100A9/S100A8: myeloid representatives of the S100: protein family as prominent players in innate immunity. Microscopy Research and Technique 60: 569–580.CrossRefPubMed Nacken, W., J. Roth, C. Sorg, and C. Kerkhoff. 2003. S100A9/S100A8: myeloid representatives of the S100: protein family as prominent players in innate immunity. Microscopy Research and Technique 60: 569–580.CrossRefPubMed
3.
Zurück zum Zitat Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P.A. Tessier. 2003. Proinflammatory activities of S100 proteins: S100A8, S100A9, And S100A8/A9 induce neutrophil chemotaxis and adhesion. The Journal of Immunology 170: 3233–3242.CrossRefPubMed Ryckman, C., K. Vandal, P. Rouleau, M. Talbot, and P.A. Tessier. 2003. Proinflammatory activities of S100 proteins: S100A8, S100A9, And S100A8/A9 induce neutrophil chemotaxis and adhesion. The Journal of Immunology 170: 3233–3242.CrossRefPubMed
4.
Zurück zum Zitat Kane, D., J. Roth, M. Frosch, T. Vogl, B. Bresnihan, and O. FitzGerald. 2003. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis & Rheumatology 48: 1676–1685.CrossRef Kane, D., J. Roth, M. Frosch, T. Vogl, B. Bresnihan, and O. FitzGerald. 2003. Increased perivascular synovial membrane expression of myeloid-related proteins in psoriatic arthritis. Arthritis & Rheumatology 48: 1676–1685.CrossRef
5.
Zurück zum Zitat Hammer, H.B., S. Odegard, M.K. Fagerhol, R. Landewé, D. van der Heijde, T. Uhlig, P. Mowinckel, and T.K. Kvien. 2007. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 66: 1093–1097.CrossRefPubMedPubMedCentral Hammer, H.B., S. Odegard, M.K. Fagerhol, R. Landewé, D. van der Heijde, T. Uhlig, P. Mowinckel, and T.K. Kvien. 2007. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Annals of the Rheumatic Diseases 66: 1093–1097.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Marionnet, C., F. Bernerd, A. Dumas, F. Verrecchia, K. Mollier, D. Compan, B. Bernard, M. Lahfa, J. Leclaire, C. Medaisko, B. Mehul, S. Seité, A. Mauviel, and L. Dubertret. 2003. Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 121: 1447–1458.CrossRefPubMed Marionnet, C., F. Bernerd, A. Dumas, F. Verrecchia, K. Mollier, D. Compan, B. Bernard, M. Lahfa, J. Leclaire, C. Medaisko, B. Mehul, S. Seité, A. Mauviel, and L. Dubertret. 2003. Modulation of gene expression induced in human epidermis by environmental stress in vivo. Journal of Investigative Dermatology 121: 1447–1458.CrossRefPubMed
7.
Zurück zum Zitat Benoit, S., A. Toksoy, M. Ahlmann, M. Schmidt, C. Sunderkötter, D. Foell, M. Pasparakis, J. Roth, and M. Goebeler. 2006. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. British Journal of Dermatology 155: 62–66.CrossRefPubMed Benoit, S., A. Toksoy, M. Ahlmann, M. Schmidt, C. Sunderkötter, D. Foell, M. Pasparakis, J. Roth, and M. Goebeler. 2006. Elevated serum levels of calcium-binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis. British Journal of Dermatology 155: 62–66.CrossRefPubMed
8.
Zurück zum Zitat Foell, D., H. Wittkowski, Z. Ren, J. Turton, G. Pang, J. Daebritz, J. Ehrchen, J. Heidemann, T. Borody, J. Roth, and R. Clancy. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. The Journal of Pathology 216: 183–192.CrossRefPubMed Foell, D., H. Wittkowski, Z. Ren, J. Turton, G. Pang, J. Daebritz, J. Ehrchen, J. Heidemann, T. Borody, J. Roth, and R. Clancy. 2008. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. The Journal of Pathology 216: 183–192.CrossRefPubMed
9.
10.
Zurück zum Zitat Guignard, F., J. Mauel, and M. Markert. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 309: 395–401.CrossRefPubMedPubMedCentral Guignard, F., J. Mauel, and M. Markert. 1995. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochemical Journal 309: 395–401.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontologica Scandinavica 59: 124–130.CrossRefPubMed Kaisho, T., and S. Akira. 2001. Toll-like receptors and their signaling mechanism in innate immunity. Acta Odontologica Scandinavica 59: 124–130.CrossRefPubMed
12.
Zurück zum Zitat Li, Q., and B.J. Cherayil. 2003. Role of toll-like receptor 4 in macrophage activation and tolerance during salmonella enterica serovar typhimurium infection. Infection and Immunity 71: 4873–4882.CrossRefPubMedPubMedCentral Li, Q., and B.J. Cherayil. 2003. Role of toll-like receptor 4 in macrophage activation and tolerance during salmonella enterica serovar typhimurium infection. Infection and Immunity 71: 4873–4882.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chen, X., L. Zhang, I.Y. Zhang, J. Liang, H. Wang, M. Ouyang, S. Wu, A.C. da Fonseca, L. Weng, Y. Yamamoto, H. Yamamoto, R. Natarajan, and B. Badie. 2014. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Research 74: 7285–7297.CrossRefPubMedPubMedCentral Chen, X., L. Zhang, I.Y. Zhang, J. Liang, H. Wang, M. Ouyang, S. Wu, A.C. da Fonseca, L. Weng, Y. Yamamoto, H. Yamamoto, R. Natarajan, and B. Badie. 2014. RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Research 74: 7285–7297.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Friggeri, A., S. Banerjee, S. Biswas, A. de Freitas, G. Liu, A. Bierhaus, and E. Abraham. 2011. Participation of the receptor for advanced glycation end products in efferocytosis. The Journal of Immunology 186: 6191–6198.CrossRefPubMedPubMedCentral Friggeri, A., S. Banerjee, S. Biswas, A. de Freitas, G. Liu, A. Bierhaus, and E. Abraham. 2011. Participation of the receptor for advanced glycation end products in efferocytosis. The Journal of Immunology 186: 6191–6198.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Németh, J., I. Stein, D. Haag, A. Riehl, T. Longerich, E. Horwitz, K. Breuhahn, C. Gebhardt, P. Schirmacher, M. Hahn, Y. Ben-Neriah, E. Pikarsky, P. Angel, and J. Hess. 2009. S100A8 And S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251–1262.CrossRefPubMed Németh, J., I. Stein, D. Haag, A. Riehl, T. Longerich, E. Horwitz, K. Breuhahn, C. Gebhardt, P. Schirmacher, M. Hahn, Y. Ben-Neriah, E. Pikarsky, P. Angel, and J. Hess. 2009. S100A8 And S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251–1262.CrossRefPubMed
16.
Zurück zum Zitat Kwon, C.H., H.J. Moon, H.J. Park, J.H. Choi, and D.Y. Park. 2013. S100A8 And S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Molecules and Cells 35: 226–234.CrossRefPubMedPubMedCentral Kwon, C.H., H.J. Moon, H.J. Park, J.H. Choi, and D.Y. Park. 2013. S100A8 And S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Molecules and Cells 35: 226–234.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ikemoto, M., H. Murayama, H. Itoh, M. Totani, and M. Fujita. 2007. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. Clinica Chimica Acta 376: 197–204.CrossRef Ikemoto, M., H. Murayama, H. Itoh, M. Totani, and M. Fujita. 2007. Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats. Clinica Chimica Acta 376: 197–204.CrossRef
18.
Zurück zum Zitat Otsuka, K., F. Terasaki, M. Ikemoto, S. Fujita, B. Tsukada, T. Katashima, Y. Kanzaki, K. Sohmiya, T. Kono, H. Toko, M. Fujita, and Y. Kitaura. 2009. Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. European Journal of Heart Failure 11: 229–237.CrossRefPubMedPubMedCentral Otsuka, K., F. Terasaki, M. Ikemoto, S. Fujita, B. Tsukada, T. Katashima, Y. Kanzaki, K. Sohmiya, T. Kono, H. Toko, M. Fujita, and Y. Kitaura. 2009. Suppression of inflammation in rat autoimmune myocarditis by S100A8/A9 through modulation of the proinflammatory cytokine network. European Journal of Heart Failure 11: 229–237.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Okada, K., S. Arai, H. Nakase, H. Kohno, F. Nakamura, M. Takeda, Y. Toda, H. Itoh, S. Adachi, and M. Ikemoto. 2015. Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats. Biochemical and Biophysical Research Communications 456: 415–420.CrossRefPubMed Okada, K., S. Arai, H. Nakase, H. Kohno, F. Nakamura, M. Takeda, Y. Toda, H. Itoh, S. Adachi, and M. Ikemoto. 2015. Autocrine pathways involving S100A8 and/or S100A9 that are postulated to regulate the immunological functions of macrophages in rats. Biochemical and Biophysical Research Communications 456: 415–420.CrossRefPubMed
20.
Zurück zum Zitat Okada, K., S. Arai, H. Itoh, S. Adachi, M. Hayashida, H. Nakase, and M. Ikemoto. 2016. CD68 On rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Journal of Leukocyte Biology 100: 1093–1104.CrossRefPubMed Okada, K., S. Arai, H. Itoh, S. Adachi, M. Hayashida, H. Nakase, and M. Ikemoto. 2016. CD68 On rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions. Journal of Leukocyte Biology 100: 1093–1104.CrossRefPubMed
21.
22.
Zurück zum Zitat Watanabe, T., A. Kitani, P.J. Murray, and W. Strober. 2004. NOD2 Is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 5: 800–808.CrossRefPubMed Watanabe, T., A. Kitani, P.J. Murray, and W. Strober. 2004. NOD2 Is a negative regulator of toll-like receptor 2-mediated T helper type 1 responses. Nature Immunology 5: 800–808.CrossRefPubMed
23.
Zurück zum Zitat Rufini, S., C. Ciccacci, D. Di Fusco, A. Ruffa, F. Pallone, G. Novelli, L. Biancone, and P. Borgiani. 2015. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn’s disease. Digestive and Liver Disease 47: 744–750.CrossRefPubMed Rufini, S., C. Ciccacci, D. Di Fusco, A. Ruffa, F. Pallone, G. Novelli, L. Biancone, and P. Borgiani. 2015. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn’s disease. Digestive and Liver Disease 47: 744–750.CrossRefPubMed
24.
Zurück zum Zitat Salem, M., M. Ammitzboell, K. Nys, J.B. Seidelin, and O.H. Nielsen. 2015. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 11: 585–594.CrossRefPubMedPubMedCentral Salem, M., M. Ammitzboell, K. Nys, J.B. Seidelin, and O.H. Nielsen. 2015. ATG16L1: A multifunctional susceptibility factor in Crohn disease. Autophagy 11: 585–594.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kucharzik, T., C. Maaser, A. Lügering, M. Kagnoff, L. Mayer, S. Targan, and W. Domschke. 2006. Recent understanding of IBD pathogenesis: Implications for future therapies. Inflammatory Bowel Diseases 12: 1068–1083.CrossRefPubMed Kucharzik, T., C. Maaser, A. Lügering, M. Kagnoff, L. Mayer, S. Targan, and W. Domschke. 2006. Recent understanding of IBD pathogenesis: Implications for future therapies. Inflammatory Bowel Diseases 12: 1068–1083.CrossRefPubMed
26.
Zurück zum Zitat Lissner, D., M. Schumann, A. Batra, L.I. Kredel, A.A. Kühl, U. Erben, C. May, J.D. Schulzke, and B. Siegmund. 2015. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflammatory Bowel Diseases 21: 1297–1305.PubMedPubMedCentral Lissner, D., M. Schumann, A. Batra, L.I. Kredel, A.A. Kühl, U. Erben, C. May, J.D. Schulzke, and B. Siegmund. 2015. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflammatory Bowel Diseases 21: 1297–1305.PubMedPubMedCentral
27.
Zurück zum Zitat Lee, M.J., J.K. Lee, J.W. Choi, C.S. Lee, J.H. Sim, C.H. Cho, K.H. Lee, I.H. Cho, M.H. Chung, H.R. Kim, and S.K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PloS One 7: e38801.CrossRefPubMedPubMedCentral Lee, M.J., J.K. Lee, J.W. Choi, C.S. Lee, J.H. Sim, C.H. Cho, K.H. Lee, I.H. Cho, M.H. Chung, H.R. Kim, and S.K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PloS One 7: e38801.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Yoshino, T., H. Nakase, Y. Honzawa, K. Matsumura, S. Yamamoto, Y. Takeda, S. Ueno, N. Uza, S. Masuda, K. Inui, and T. Chiba. 2010. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflammatory Bowel Diseases 16: 2022–2033.CrossRefPubMed Yoshino, T., H. Nakase, Y. Honzawa, K. Matsumura, S. Yamamoto, Y. Takeda, S. Ueno, N. Uza, S. Masuda, K. Inui, and T. Chiba. 2010. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflammatory Bowel Diseases 16: 2022–2033.CrossRefPubMed
29.
Zurück zum Zitat Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997. Green mice' as a source of ubiquitous green cells. FEBS Letters 407: 313–319.CrossRefPubMed Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune. 1997. Green mice' as a source of ubiquitous green cells. FEBS Letters 407: 313–319.CrossRefPubMed
30.
Zurück zum Zitat Rutz, S., N. Kayagaki, Q.T. Phung, C. Eidenschenk, R. Noubade, X. Wang, J. Lesch, R. Lu, K. Newton, O.W. Huang, A.G. Cochran, M. Vasser, B.P. Fauber, J. DeVoss, J. Webster, L. Diehl, Z. Modrusan, D.S. Kirkpatrick, J.R. Lill, W. Ouyang, and V.M. Dixit. 2015. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518: 417–421.CrossRefPubMed Rutz, S., N. Kayagaki, Q.T. Phung, C. Eidenschenk, R. Noubade, X. Wang, J. Lesch, R. Lu, K. Newton, O.W. Huang, A.G. Cochran, M. Vasser, B.P. Fauber, J. DeVoss, J. Webster, L. Diehl, Z. Modrusan, D.S. Kirkpatrick, J.R. Lill, W. Ouyang, and V.M. Dixit. 2015. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 518: 417–421.CrossRefPubMed
31.
Zurück zum Zitat Ikemoto, M., T. Tanaka, Y. Takai, H. Murayama, K. Tanaka, and M. Fujita. 2003. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clinical Chemistry 49: 594–600.CrossRefPubMed Ikemoto, M., T. Tanaka, Y. Takai, H. Murayama, K. Tanaka, and M. Fujita. 2003. New ELISA system for myeloid-related protein complex (MRP8/14) and its clinical significance as a sensitive marker for inflammatory responses associated with transplant rejection. Clinical Chemistry 49: 594–600.CrossRefPubMed
32.
Zurück zum Zitat Koike, A., S. Arai, S. Yamada, A. Nagae, N. Saita, H. Itoh, S. Uemoto, M. Totani, and M. Ikemoto. 2012. Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: A variety of functional roles of the two proteins as regulators in acute inflammatory reaction. Inflammation 35: 409–419.CrossRefPubMed Koike, A., S. Arai, S. Yamada, A. Nagae, N. Saita, H. Itoh, S. Uemoto, M. Totani, and M. Ikemoto. 2012. Dynamic mobility of immunological cells expressing S100A8 and S100A9 in vivo: A variety of functional roles of the two proteins as regulators in acute inflammatory reaction. Inflammation 35: 409–419.CrossRefPubMed
34.
Zurück zum Zitat Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W.J. Chazin, Y. Nakatani, S. Yui, and H. Makino. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research & Therapy 8: 1–12.CrossRef Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, H. Yamamoto, W.J. Chazin, Y. Nakatani, S. Yui, and H. Makino. 2006. The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Research & Therapy 8: 1–12.CrossRef
Metadaten
Titel
Establishment of S100A8 Transgenic Rats to Understand Innate Property of S100A8 and Its Immunological Role
verfasst von
Kohki Okada
Hiroshi Itoh
Yasuhiko Kamikubo
Souichi Adachi
Masaki Ikemoto
Publikationsdatum
14.09.2017
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2018
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-017-0664-8

Weitere Artikel der Ausgabe 1/2018

Inflammation 1/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.